OakChart

Tiziana Life Sciences Ltd

TLSAHealthcare·Biotechnology·Bermuda·Micro·NASD·Nov 11 • 1:07 PM ET

0.6560+0.0458 (7.51%)
2026-11-11 19:12 CET
Market cap
78.29 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-25.19 USD m
Free cash flow, TTM
-13.46 USD m
EPS diluted, TTM
-0.20
P/E
-
Compare

Price

TLSA against its 20, 50 and 200-day averages
2050200missearnings
0.501.001.501.5M3.0MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26TLSAclose 0.6620-day 0.8450-day 0.94200-day 1.170.6652w high52w low

65.5% under the 52-week high of 1.90 on 2 Dec 2025. 52-week low 0.57 on 5 Nov 2026. Last 15 sessions, 78.1% high to low

Profile

TLSA
52-week range, 6% of the way up
0.571.90

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in developing therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer's. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom.

Employees10
IPONov 20, 2018
Beta0.49
ATR, 14d0.08
Rel volume0.39
Short float4.54%
Insider own49.84%
Inst own1.99%

Snapshot

6 groups

Valuation

Index-
Market Cap84.17M
Enterprise Value81.92M
Income-25.19M
Sales0.00M
Book/sh-0.02
Cash/sh0.02
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees10
IPONov 20, 2018

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B-
P/C26.47
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio0.69
Current Ratio0.69
Debt/Eq-
LT Debt/Eq-
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.20
EPS next Y-0.19
EPS next Q-
EPS this Y-7.03%
EPS next Y-9.06%
EPS next 5Y-5.88%
EPS past 3/5Y-0.89% -0.19%
Sales past 3/5Y- -
EPS Y/Y TTM-78.92%
Sales Y/Y TTM-
EPS Q/Q-101.04%
Sales Q/Q-
EarningsSep 18
EPS/Sales Surpr.1.50% -

Ownership

Insider Own49.84%
Insider Trans1.57%
Inst Own1.99%
Inst Trans-15.23%
ROA-178.26%
ROE-780.60%
ROIC-
Gross Margin-
Oper. Margin-
Profit Margin-
SMA20-21.59%
SMA50-30.16%
SMA200-44.16%
Trades-

Technical

Shs Outstand128.03M
Shs Float64.36M
Short Float4.54%
Short Ratio3.98
Short Interest2.92M
52W High1.90 -65.47%
52W Low0.57 15.68%
Volatility12.17% 10.19%
ATR (14)0.08
RSI (14)34.80
Beta0.49
Rel Volume0.39
Avg Volume735.03K
Volume167,363

Performance

Perf Week2.82%
Perf Month-39.82%
Perf Quarter-36.92%
Perf Half Y-56.27%
Perf YTD-55.97%
Perf Year-62.30%
Perf 3Y12.14%
Perf 5Y-52.46%
Perf 10Y-
Recom1.00
Target Price7.98
Prev Close0.61
Price0.66
Change %7.51%

Analyst ratings

latest 3 of 3
DateActionAnalystRating changeTargetImplied
Sep 03, 2026InitiatedBBTIG ResearchBuy$7+967.1%
Dec 22, 2020InitiatedRB. Riley SecuritiesBuy$8+1,119.5%
Dec 17, 2018InitiatedLLaidlawBuy

Peers

Mkt cap
TickerCompanyMkt cap
IMUXImmunic Inc111.34M
COYACoya Therapeutics Inc75.30M
CLNNClene Inc61.48M
INMBINmune Bio Inc35.29M
ACIUAC Immune SA234.08M
ALECAlector Inc416.11M
AVXLAnavex Life Sciences Corp101.92M
ANNXAnnexon Inc787.51M
ANVSAnnovis Bio Inc35.30M
TNXPTonix Pharmaceuticals Holding Corp75.49M

Insider trading

3 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Elrifi IvorChief Executive OfficerAug 05 '26Buy1.00237,616237,6164,793,684Aug 06 09:30 AM
Elrifi IvorChief Executive OfficerAug 04 '26Buy0.9783,80781,2934,556,068Aug 06 09:30 AM
Elrifi IvorChief Executive OfficerAug 03 '26Buy1.00667,000667,0004,472,261Aug 05 04:30 PM

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026S12026-09-18-0.079-0.080-0.0970.00-1
2025S22026-06-18-0.110-0.090-0.1080.00-1
2025S12025-10-01-0.070-0.070-0.048--1
2024S22025-06-05-0.070--0.0660.00--
2021S12021-09-24-0.202-0.059-0.1160.000.001
2020S22021-07-13-0.081--0.1230.00--
2020Q42021-05-18-0.028--0.00--
2020S12020-09-30-0.066-0.079-0.033---
2019S22020-09-15-0.025--0.033--1
2026S2---0.100---1
2027S1---0.090---1
2027S2---0.100---1

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-0.053-0.050-0.068--
2020FY-0.338-0.067-0.1540.000.00
2021FY-0.240-0.114-0.239--
2022FY-0.150-0.372-0.1520.00-
2023FY-0.150--0.1730.00-
2024FY-0.109--0.00-
2025FY-0.159-0.160-0.1580.000.00
2026FY--0.172--0.00
2027FY--0.187---
2028FY--0.191---
2029FY--0.194---
2030FY--1.291--97.54

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026S2R2026-11-05110-0.10-0.10-0.10
2026S2R2026-10-29101-0.10-0.10-0.10
2026S2R2026-10-02101-0.10-0.10-0.10
2026S2R2026-09-18101-0.10-0.10-0.10
2026S2R2026-09-01100-0.10-0.10-0.10
2026S2E2026-11-05110-0.10-0.10-0.10
2026S2E2026-10-29101-0.10-0.10-0.10
2026S2E2026-10-02101-0.10-0.10-0.10
2026S2E2026-09-18101-0.10-0.10-0.10
2026S2E2026-09-01100-0.10-0.10-0.10
2026S2E2026-06-18100-0.08-0.08-0.08
2026S2E2026-05-19100-0.08-0.08-0.08
2026S2E2025-10-28100-0.10-0.10-0.10
2026S2E2025-10-27100-0.10-0.10-0.10

Estimate history

EPS, annual-0.082-0.062-0.068-0.154-0.239-0.152-0.173-0.111-0.156
Period201720182019202020212022202320242025
EPS, quarterly
Period
Sales, annual000000000
Period201720182019202020212022202320242025
Sales, quarterly
Period
Shares, annual125.055136.464136.655194.612102.273102.273103.088111.463120.507
Period201720182019202020212022202320242025
Shares, quarterly
Period

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.000.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.300.230.120.100.050.140.090.250.02
Gross Profit-0.30-0.23-0.12-0.10-0.05-0.14-0.09-0.25-0.02
Selling, General and Administrative Excl. Other23.4521.0515.5116.3717.7229.1330.049.5010.15
Research and Development13.4710.285.238.1112.9613.215.983.715.51
Other Operating Expense0.000.000.000.000.00-0.000.000.00
Operating Income-23.75-21.28-15.64-16.46-17.77-29.27-30.13-9.75-10.16
Interest Expense0.020.020.010.010.010.180.320.090.01
Unusual Expense2.48-1.751.760.400.870.000.28--
Net Income Before Taxes-25.19-18.43-16.75-17.24-15.40-26.66-28.30-10.01-9.88
Income Taxes0.000.00-4.880.450.00-3.24-2.20-0.69-1.95
Consolidated Net Income-25.19-18.43-11.86-17.69-15.40-23.42-26.09-9.32-7.93
Net Income From Continuing Operations-25.19-18.43-11.86-17.69-15.40-23.42-26.09-9.32-7.93
Net Income-25.19-18.43-11.86-17.69-15.40-23.42-26.09-9.32-7.93
EPS (Recurring)-0.18-0.17-0.10-0.17-0.15-0.24-0.15-0.07-0.06
EPS (Basic, Before Extraordinaries)-0.20-0.16-0.11-0.17-0.15-0.24-0.15-0.07-0.06
EPS (Diluted)-0.20-0.16-0.11-0.17-0.15-0.24-0.15-0.07-0.06
EBITDA-23.45-21.05-15.51-16.37-17.72-29.13-30.04-9.50-10.15
Non-Operating Income (Expense)1.581.120.66-0.363.252.792.43-0.160.30
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.053.092.341.73-1.414.193.881.030.54
Shares Outstanding128.03120.51111.46103.09102.27102.27194.61136.65136.46
Market Capitalization78.2978.2977.04108.98116.48186.83193.9414.5412.71

Income statement, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S22023S12022S2
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.160.150.090.060.060.040.060.05
Gross Profit-0.16-0.15-0.09-0.06-0.06-0.04-0.06-0.05
Selling, General and Administrative Excl. Other11.2612.188.879.136.386.1910.189.99
Research and Development6.437.043.242.652.584.833.295.49
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-11.42-12.33-8.96-9.19-6.44-6.23-10.23-10.04
Interest Expense0.000.020.000.010.000.010.010.01
Unusual Expense1.211.28-3.030.181.590.400.000.00
Net Income Before Taxes-12.39-12.80-5.63-8.77-7.98-8.63-8.62-10.88
Income Taxes0.000.000.00-1.56-3.330.450.000.00
Consolidated Net Income-12.39-12.80-5.63-7.21-4.65-9.07-8.62-10.88
Net Income From Continuing Operations-12.39-12.80-5.63-7.21-4.65-9.07-8.62-10.88
Net Income-12.39-12.80-5.63-7.21-4.65-9.07-8.62-10.88
EPS (Recurring)-0.09-0.10-0.07-0.06-0.03-0.09-0.08-0.11
EPS (Basic, Before Extraordinaries)-0.10-0.11-0.05-0.07-0.05-0.09-0.08-0.11
EPS (Diluted)-0.10-0.11-0.05-0.07-0.05-0.09-0.08-0.11
EBITDA-11.26-12.18-8.87-9.13-6.38-6.19-10.18-9.99
Non-Operating Income (Expense)0.241.340.300.610.05-1.981.62-0.84
Stock Option Compensation Expense0.582.470.621.670.660.810.920.93
Shares Outstanding128.03120.51118.82111.46104.04103.09102.27102.27
Market Capitalization78.29177.09176.1177.04178.85108.98132.61116.48

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments4.013.721.1818.1242.1965.910.205.300.06
Short Term Receivables4.263.696.055.995.313.981.291.292.06
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets0.290.090.100.171.190.380.030.040.33
Total Current Assets8.557.517.3424.2848.6870.271.526.642.45
Net Property, Plant & Equipment0.500.190.290.390.020.360.440.010.02
Total Investments and Advances2.443.594.551.810.000.000.000.000.00
Long-Term Note Receivable-----0.000.15--
Intangible Assets0.000.000.000.000.130.13-0.000.00
Other Assets0.000.000.000.000.000.000.290.280.00
Total Assets11.5011.2812.1826.4848.8370.762.406.922.48
Short Term Debt Incl. Current Port. of LT Debt0.220.110.140.121.362.310.880.450.32
Accounts Payable0.000.000.000.000.000.000.000.000.00
Other Current Liabilities10.997.246.406.546.195.686.515.954.44
Total Current Liabilities11.217.356.546.667.557.997.396.404.75
Long Term Debt0.230.000.110.240.000.290.540.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.00-
Other Liabilities0.000.000.000.000.000.000.000.000.00
Total Liabilities11.447.356.656.917.558.287.936.404.75
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity0.053.945.5419.5741.2862.48-5.540.52-2.28
Total Shareholders Equity0.053.945.5419.5741.2862.48-5.540.52-2.28
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity0.053.945.5419.5741.2862.48-5.540.52-2.28
Total Liabilities & Stockholders Equity11.5011.2812.1826.4848.8370.762.406.922.48
Book Value Per Share0.000.040.050.190.400.32-0.040.00-0.02
Tangible Book Value Per Share0.000.040.050.190.400.32-0.040.00-0.02
Full-Time Employees10999811101011
Price to Book Ratio-28.43--------
Return on Assets-161.82-101.10-91.52-40.89-39.16-71.34-200.05-168.80-200.01
Return on Equity-924.32-250.49-140.92-50.61-45.14-91.64---
Return on Invested Capital-6,444.41-301.40-313.39-77.71-56.73-41.57--1,515.67-
Quick Ratio0.761.021.123.646.458.790.211.040.52
Current Ratio0.761.021.123.646.458.790.211.040.52

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-25.19-18.43-16.75-17.24-15.40-26.66-28.30-10.01-9.88
Depreciation0.300.230.120.100.050.140.090.250.02
Other Funds (Non Cash)4.422.2915.653.03-3.115.5316.582.683.32
Funds from Operations-20.46-15.91-0.97-14.12-18.45-20.99-11.63-7.08-6.54
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital7.083.06-0.55-1.58-1.16-0.77-0.290.291.94
Cash from Operating Activities-13.38-12.85-1.53-15.70-19.62-21.76-11.92-6.79-4.60
Capital Expenditures-0.08-0.02-0.020.000.00-0.02-0.13-0.000.00
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments-2.890.000.00-1.00-2.680.000.000.000.00
Purchase of Investments0.000.000.00-1.00-2.680.000.000.000.00
Sale Or Maturity of Investments-2.890.000.000.000.000.000.000.000.00
Other Uses0.000.00-0.05-0.25-1.320.000.000.000.00
Other Sources3.063.060.000.000.000.150.000.000.00
Cash from Investing Activities0.103.04-0.07-1.25-4.000.13-0.13-0.000.00
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock9.4410.204.650.160.000.1373.961.8810.09
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock9.4410.204.650.160.000.1373.961.8810.09
Proceedsfrom Stock Options9.2910.064.570.020.000.0069.440.008.58
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities9.1610.014.510.04-0.06-0.0273.681.6810.09
Exchange Rate Effect0.050.08-0.37-0.03-0.40-1.98---
Net Change in Cash-4.070.292.54-16.94-24.06-23.6461.64-5.125.49
Free Cash Flow-13.46-12.87-1.54-15.70-19.61-21.78-11.92-6.80-4.60
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S2
Cash & Short Term Investments3.184.017.253.721.131.18
Short Term Receivables4.324.264.953.696.276.05
Inventories0.000.000.000.000.000.00
Other Current Assets1.940.290.520.090.360.10
Total Current Assets9.448.5512.727.517.757.34
Net Property, Plant & Equipment0.990.500.150.190.250.29
Total Investments and Advances1.242.443.733.592.974.55
Intangible Assets0.000.000.000.000.000.00
Other Assets0.000.000.000.000.000.00
Total Assets11.6611.5016.6011.2810.9612.18
Short Term Debt Incl. Current Port. of LT Debt0.110.220.110.110.140.14
Accounts Payable0.000.000.000.000.000.00
Income Tax Payable0.00-0.10---
Other Current Liabilities13.4810.997.197.248.936.40
Total Current Liabilities13.5811.217.407.359.076.54
Long Term Debt0.830.230.000.000.040.11
Other Liabilities0.000.000.000.000.000.00
Total Liabilities14.4111.447.407.359.116.65
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-2.750.059.203.941.865.54
Total Shareholders Equity-2.750.059.203.941.865.54
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity-2.750.059.203.941.865.54
Total Liabilities & Stockholders Equity11.6611.5016.6011.2810.9612.18
Book Value Per Share-0.020.000.080.040.020.05
Tangible Book Value Per Share-0.020.000.080.040.020.05
Price to Book Ratio-28.4319.2444.75---
Return on Assets-178.26-161.82-93.18-101.10-96.74-91.52
Return on Equity-780.60-924.32-232.31-250.49-181.23-140.92
Return on Invested Capital--4,475.17-61.22-183.16-245.98-160.74
Quick Ratio0.690.761.721.020.851.12
Current Ratio0.690.761.721.020.851.12

Cash flow, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S2
Net Income-12.39-12.80-5.63-8.77-7.98-8.62
Depreciation0.160.150.090.060.060.04
Other Funds (Non Cash)2.551.870.429.016.630.67
Funds from Operations-9.68-10.78-5.130.31-1.28-7.91
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital2.334.76-1.70-2.241.683.61
Cash from Operating Activities-7.36-6.02-6.82-1.930.40-4.31
Capital Expenditures-0.06-0.02-0.01-0.01-0.010.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.00-2.892.890.000.00-1.00
Purchase of Investments0.000.000.000.000.00-1.00
Sale Or Maturity of Investments0.00-2.892.890.000.000.00
Other Uses0.000.000.00-0.050.000.00
Other Sources0.003.060.000.000.000.00
Cash from Investing Activities-0.060.162.88-0.06-0.01-1.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock6.642.797.414.650.000.16
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock6.642.797.414.650.000.16
Proceedsfrom Stock Options6.642.657.414.570.000.02
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities6.512.657.364.57-0.070.08
Exchange Rate Effect0.07-0.030.110.00-0.37-0.19
Net Change in Cash-0.83-3.243.532.59-0.05-5.41
Free Cash Flow-7.42-6.04-6.83-1.930.39-4.31

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-304.54%2.9M64.4M782.44K
2026-10-154.34%2.8M64.4M750.91K
2026-09-304.10%2.6M64.4M692.44K
2026-09-152.65%1.7M65.4M582.65K
2026-08-312.60%1.7M65.4M537.62K
2026-08-142.60%1.7M65.4M423.08K
2026-07-312.52%1.7M67.5M238.22K
2026-07-151.84%1.2M67.6M222.38K
2026-06-302.49%1.6M62.9M206.82K
2026-06-152.73%1.6M58.2M207.19K
2026-05-292.51%1.5M58.2M185.53K
2026-05-152.32%1.4M60.9M147.98K
2026-04-302.23%1.4M60.9M149.97K
2026-04-152.11%1.3M60.9M196.73K
2026-03-312.29%1.5M63.5M204.56K
2026-03-132.35%1.5M63.5M249.41K
2026-02-272.41%1.5M63.5M292.27K
2026-02-132.30%1.5M63.5M312.23K
2026-01-302.38%1.5M63.5M311.31K
2026-01-152.51%1.6M63.5M286.20K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.000.150.099.3414870.000.423-0.0200.000
call5.000.003.800.0011.3050.000.000.394-0.0240.000
call7.500.000.200.000.0000.000.000.0000.0000.000
put2.500.004.400.000.0000.000.00-0.584-0.0200.000
put5.002.006.903.780.0001.000.000.0000.0000.000
put7.504.509.400.000.0000.000.00-0.533-0.0290.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-09SEC
2026-11-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-09SEC
2026-11-056-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-05SEC
2026-11-026-K/A2026-10-16SEC
2026-11-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-02SEC
2026-10-216-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-21SEC
2026-10-166-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-16SEC
2026-10-166-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-16SEC
2026-09-306-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-30SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-09-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-28SEC
2026-09-216-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-21SEC
2026-09-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-17SEC
2026-08-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-24SEC
2026-08-074/A2026-07-21SEC
2026-08-074/A2026-06-12SEC
2026-08-064Statement of changes in beneficial ownership of securities2026-08-04SEC
2026-08-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-06SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-08-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-04SEC
2026-07-316-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-31SEC
2026-07-233Initial statement of beneficial ownership of securities2026-03-18SEC
2026-07-234Statement of changes in beneficial ownership of securities2026-06-21SEC
2026-07-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-22SEC
2026-06-256-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-25SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-12SEC
2026-06-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-15SEC
2026-05-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-28SEC
2026-05-223Initial statement of beneficial ownership of securities2026-03-18SEC
2026-05-216-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-21SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-08985.91K300
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Dauntless Investment Group, LLC0.91%
Mid-American Wealth Advisory Group, Inc.0.35%
Zhang Financial LLC0.10%
GOLDMAN SACHS GROUP INC0.09%
CITADEL ADVISORS LLC0.06%
Focus Partners Wealth0.06%
HSBC HOLDINGS PLC0.05%
MORGAN STANLEY0.04%
China Universal Asset Management Co., Ltd.0.04%
HRT FINANCIAL LP0.04%

Funds

Fund% owned
Goldman Sachs Absolute Return Tracker Fund0.10%
Fidelity Nasdaq Composite Index Fund0.03%
Blackstone Alternative Multi-Strategy Fund0.00%

OakChart. TLSA. Cached 15 minutes.